95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.93%
Negative revenue growth while FNV stands at 2.43%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-17.34%
Negative gross profit growth while FNV is at 10.18%. Joel Greenblatt would examine cost competitiveness or demand decline.
-16.55%
Negative EBIT growth while FNV is at 30.35%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-16.55%
Negative operating income growth while FNV is at 6.80%. Joel Greenblatt would press for urgent turnaround measures.
-15.36%
Negative net income growth while FNV stands at 40.92%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.00%
Negative EPS growth while FNV is at 38.46%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.00%
Negative diluted EPS growth while FNV is at 40.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.05%
Share reduction more than 1.5x FNV's 0.90%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.12%
Diluted share reduction more than 1.5x FNV's 0.41%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-44.44%
Dividend reduction while FNV stands at 25.77%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-25.60%
Negative OCF growth while FNV is at 4.55%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-394.81%
Negative FCF growth while FNV is at 8.64%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
474.43%
10Y revenue/share CAGR above 1.5x FNV's 81.44%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
155.90%
5Y revenue/share CAGR above 1.5x FNV's 81.44%. David Dodd would look for consistent product or market expansions fueling outperformance.
104.72%
3Y revenue/share CAGR similar to FNV's 97.32%. Walter Schloss would assume both companies experience comparable short-term cycles.
318.78%
10Y OCF/share CAGR above 1.5x FNV's 31.97%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
198.21%
5Y OCF/share CAGR above 1.5x FNV's 31.97%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
151.07%
3Y OCF/share CAGR above 1.5x FNV's 29.01%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
2734.24%
Net income/share CAGR above 1.5x FNV's 262.84% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
292.06%
5Y net income/share CAGR 1.25-1.5x FNV's 262.84%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
215.81%
3Y net income/share CAGR similar to FNV's 224.70%. Walter Schloss would attribute it to shared growth factors or demand patterns.
3071.55%
10Y equity/share CAGR above 1.5x FNV's 46.92%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
146.06%
5Y equity/share CAGR above 1.5x FNV's 46.92%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
59.98%
3Y equity/share CAGR above 1.5x FNV's 33.42%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
51.09%
AR growth of 51.09% while FNV is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
No Data
No Data available this quarter, please select a different quarter.
-0.34%
Negative asset growth while FNV invests at 5.40%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.54%
Similar to FNV's 4.47%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-11.10%
We’re deleveraging while FNV stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-8.05%
We cut SG&A while FNV invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.